Approaches for defining the Hsp90-dependent proteome

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 3, 2012, Pages 656-667

  Hartson, Steven D ^a   Matts, Robert L ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

High throughput screen; Hsp90 inhibitor; Hsp90 interactome; LC MS MS; Proteomics

Indexed keywords

GLUCOSE; HEAT SHOCK PROTEIN 90; PROTEOME;

BIOINFORMATICS; CYTOSKELETON; DATA BASE; GENETIC SCREENING; GLUCOSE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; INTRACELLULAR TRANSPORT; MASS SPECTROMETRY; MOLECULAR GENETICS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEOMICS; REVIEW;

DRUG DISCOVERY; HSP90 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; PROTEOME; PROTEOMICS;

EID: 84857049211     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.08.013     Document Type: Review

References (110)

1. Pearl L.H., Prodromou C. Structure, function, and mechanism of the Hsp90 molecular chaperone. Adv. Prot. Chem. 2002, 59:157-185.
2. Pratt W.B., Toft D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. (Maywood) 2003, 228:111-133.
3. Hessling M., Richter K., Buchner J. Dissection of the ATP-induced conformational cycle of the molecular chaperone Hsp90. Nat. Struct. Mol. Biol. 2009, 16:287-293.
4. Krukenberg K.A., Street T.O., Lavery L.A., Agard D.A. Conformational dynamics of the molecular chaperone Hsp90. Q. Rev. Biophys. 2011, 44:229-255.
5. Mickler M., Hessling M., Ratzke C., Buchner J., Hugel T. The large conformational changes of Hsp90 are only weakly coupled to ATP hydrolysis. Nat. Struct. Mol. Biol. 2009, 16:281-286.
6. Pearl L.H., Prodromou C. Structure and mechanism of the hsp90 molecular chaperone machinery. Annu. Rev. Biochem. 2006, 75:271-294.
7. Pearl L.H., Prodromou C., Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem. J. 2008, 410:439-453.
8. Saibil H.R. Chaperone machines in action. Curr. Opin. Struct. Biol. 2008, 18:35-42.
9. Zuehlke A., Johnson J.L. Hsp90 and co-chaperones twist the functions of diverse client proteins. Biopolymers 2010, 93:211-217.
10. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., Neckers L.M. Inhibition of heat shock protein HSP90-pp 60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:8324-8328.
11. Matts R.L., Brandt G.E., Lu Y., Dixit A., Mollapour M., Wang S., Donnelly A.C., Neckers L., Verkhivker G., Blagg B.S. A systematic protocol for the characterization of Hsp90 modulators. Bioorg. Med. Chem. 2011, 19:684-692.
12. Peterson L.B., Blagg B.S.J. To fold or not to fold: modulation and consequences of Hsp90 inhibition. Future Med. Chem. 2009, 1:267-283.
13. Bishop S.C., Burlison J.A., Blagg B.S. Hsp90: a novel target for the disruption of multiple signaling cascades. Curr. Cancer Drug Targets 2007, 7:369-388.
14. Neckers L. Heat shock protein 90: the cancer chaperone. J. Biosci. 2007, 32:517-530.
15. Gong Y., Kakihara Y., Krogan N., Greenblatt J., Emili A., Zhang Z., Houry W.A. An atlas of chaperone-protein interactions in Saccharomyces cerevisiae: implications to protein folding pathways in the cell. Mol. Syst. Biol. 2009, 5:275.
16. Zhao R., Davey M., Hsu Y.C., Kaplanek P., Tong A., Parsons A.B., Krogan N., Cagney G., Mai D., Greenblatt J., Boone C., Emili A., Houry W.A. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 2005, 120:715-727.
17. Zhao R., Houry W.A. Molecular interaction network of the Hsp90 chaperone system. Adv. Exp. Med. Biol. 2007, 594:27-36.
18. McClellan A.J., Xia Y., Deutschbauer A.M., Davis R.W., Gerstein M., Frydman J. Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell 2007, 131:121-135.
19. Echeverria P., Forafonov F., Pandey D., Muhlebach G., Picard D. Detection of changes in gene regulatory patterns, elicited by perturbations of the Hsp90 molecular chaperone complex, by visualizing multiple experiments with an animation. BioData Mining 2011, 4:15.
20. Johnson J.L., Brown C. Plasticity of the Hsp90 chaperone machine in divergent eukaryotic organisms. Cell Stress Chaperones 2009, 14:83-94.
21. Kimura Y., Yahara I., Lindquist S. Role of the protein chaperone YDJ1 in establishing Hsp90-mediated signal transduction pathways. Science 1995, 268:1362-1365.
22. Nathan D.F., Vos M.H., Lindquist S. Identification of SSF1, CNS1, and HCH1 as multicopy suppressors of a Saccharomyces cerevisiae Hsp90 loss-of-function mutation. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:1409-1414.
23. Millson S.H., Truman A.W., King V., Prodromou C., Pearl L.H., Piper P.W. A two-hybrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase, Slt2p (Mpk1p). Eukaryot. Cell 2005, 4:849-860.
24. Millson S.H., Truman A.W., Wolfram F., King V., Panaretou B., Prodromou C., Pearl L.H., Piper P.W. Investigating the protein-protein interactions of the yeast Hsp90 chaperone system by two-hybrid analysis: potential uses and limitations of this approach. Cell Stress Chaperones 2004, 9:359-368.
25. Te J., Jia L., Rogers J., Miller A., Hartson S.D. Novel subunits of the mammalian Hsp90 signal transduction chaperone. J. Proteome Res. 2007, 6:1963-1973.
26. Wang X., Heuvelman D.M., Carroll J.A., Dufield D.R., Masferrer J.L. Geldanamycin-induced PCNA degradation in isolated Hsp90 complex from cancer cells. Cancer Invest. 2010, 28:635-641.
27. Sa-Correia I., Teixeira M.C. 2D electrophoresis-based expression proteomics: a microbiologist's perspective. Expert Rev. Proteomics 2010, 7:943-953.
28. Bunai K., Yamane K. Effectiveness and limitation of two-dimensional gel electrophoresis in bacterial membrane protein proteomics and perspectives. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 815:227-236.
29. Herbert B.R., Harry J.L., Packer N.H., Gooley A.A., Pedersen S.K., Williams K.L. What place for polyacrylamide in proteomics?. Trends Biotechnol. 2001, 19:S3-S9.
30. Nilsson C.L., Davidsson P. New separation tools for comprehensive studies of protein expression by mass spectrometry. Mass Spectrom. Rev. 2000, 19:390-397.
31. Westermeier R., Marouga R. Protein detection methods in proteomics research. Biosci. Rep. 2005, 25:19-32.
32. Unlu M., Morgan M.E., Minden J.S. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18:2071-2077.
33. Hernandez P., Muller M., Appel R.D. Automated protein identification by tandem mass spectrometry: issues and strategies. Mass Spectrom. Rev. 2006, 25:235-254.
34. Maloney A., Clarke P.A., Naaby-Hansen S., Stein R., Koopman J.O., Akpan A., Yang A., Zvelebil M., Cramer R., Stimson L., Aherne W., Banerji U., Judson I., Sharp S., Powers M., deBilly E., Salmons J., Walton M., Burlingame A., Waterfield M., Workman P. Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Res. 2007, 67:3239-3253.
35. Muroi M., Kazami S., Noda K., Kondo H., Takayama H., Kawatani M., Usui T., Osada H. Application of proteomic profiling based on 2D-DIGE for classification of compounds according to the mechanism of action. Chem. Biol. 2010, 17:460-470.
36. Yao J.Q., Liu Q.H., Chen X., Yang Q., Xu Z.Y., Hu F., Wang L., Li J.M. Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells. J. Biomed. Sci. 2010, 17:30.
37. Barrett J., Brophy P.M., Hamilton J.V. Analysing proteomic data. Int. J. Parasitol. 2005, 35:543-553.
38. Hardouin J. Protein sequence information by matrix-assisted laser desorption/ionization in-source decay mass spectrometry. Mass Spectrom. Rev. 2007, 26:672-682.
39. Palagi P.M., Hernandez P., Walther D., Appel R.D. Proteome informatics I: bioinformatics tools for processing experimental data. Proteomics 2006, 6:5435-5444.
40. Thiede B., Hohenwarter W., Krah A., Mattow J., Schmid M., Schmidt F., Jungblut P.R. Peptide mass fingerprinting. Methods 2005, 35:237-247.
41. Yates J.R. Database searching using mass spectrometry data. Electrophoresis 1998, 19:893-900.
42. Roe M.R., Griffin T.J. Gel-free mass spectrometry-based high throughput proteomics: tools for studying biological response of proteins and proteomes. Proteomics 2006, 6:4678-4687.
43. Washburn M.P., Wolters D., Yates J.R. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19:242-247.
44. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17:994-999.
45. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., Purkayastha S., Juhasz P., Martin S., Bartlet-Jones M., He F., Jacobson A., Pappin D.J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3:1154-1169.
46. Gupta N., Pevzner P.A. False discovery rates of protein identifications: a strike against the two-peptide rule. J. Proteome Res. 2009, 8:4173-4181.
47. Aebersold R., Goodlett D.R. Mass spectrometry in proteomics. Chem. Rev. 2001, 101:269-295.
48. Gallien S., Duriez E., Domon B. Selected reaction monitoring applied to proteomics. J. Mass Spectrom. 2011, 46:298-312.
49. Haas W., Faherty B.K., Gerber S.A., Elias J.E., Beausoleil S.A., Bakalarski C.E., Li X., Villen J., Gygi S.P. Optimization and use of peptide mass measurement accuracy in shotgun proteomics. Mol. Cell. Proteomics 2006, 5:1326-1337.
50. Lopez J.L., Marina A., Alvarez G., Vazquez J. Application of proteomics for fast identification of species-specific peptides from marine species. Proteomics 2002, 2:1658-1665.
51. Remily-Wood E.R., Liu R.Z., Xiang Y., Chen Y., Thomas C.E., Rajyaguru N., Kaufman L.M., Ochoa J.E., Hazlehurst L., Pinilla-Ibarz J., Lancet J., Zhang G., Haura E., Shibata D., Yeatman T., Smalley K.S., Dalton W.S., Huang E., Scott E., Bloom G.C., Eschrich S.A., Koomen J.M. A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer. Proteomics Clin. Appl. 2011.
52. Southan C. Has the yo-yo stopped? An assessment of human protein-coding gene number. Proteomics 2004, 4:1712-1726.
53. Altschul S.F., Boguski M.S., Gish W., Wootton J.C. Issues in searching molecular sequence databases. Nat. Genet. 1994, 6:119-129.
54. Nesvizhskii A.I., Aebersold R. Interpretation of shotgun proteomic data: the protein inference problem. Mol. Cell. Proteomics 2005, 4:1419-1440.
55. Carr S., Aebersold R., Baldwin M., Burlingame A., Clauser K., Nesvizhskii A. The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data. Mol. Cell. Proteomics 2004, 3:531-533.
56. Bradshaw R.A., Burlingame A.L., Carr S., Aebersold R. Reporting protein identification data: the next generation of guidelines. Mol. Cell. Proteomics 2006, 5:787-788.
57. Cottingham K. MCP ups the ante by mandating raw-data deposition. J. Proteome Res. 2009, 8:4887-4888.
58. Caplan A.J., Ma'ayan A., Willis I.M. Multiple kinases and system robustness: a link between Cdc37 and genome integrity. Cell Cycle 2007, 6:3145-3147.
59. Boulon S., Pradet-Balade B., Verheggen C., Molle D., Boireau S., Georgieva M., Azzag K., Robert M.C., Ahmad Y., Neel H., Lamond A.I., Bertrand E. HSP90 and its R2TP/Prefoldin-like cochaperone are involved in the cytoplasmic assembly of RNA polymerase II. Mol. Cell 2010, 39:912-924.
60. Boulon S., Marmier-Gourrier N., Pradet-Balade B., Wurth L., Verheggen C., Jady B.E., Rothe B., Pescia C., Robert M.C., Kiss T., Bardoni B., Krol A., Branlant C., Allmang C., Bertrand E., Charpentier B. The Hsp90 chaperone controls the biogenesis of L7Ae RNPs through conserved machinery. J. Cell Biol. 2008, 180:579-595.
61. Skarra D.V., Goudreault M., Choi H., Mullin M., Nesvizhskii A.I., Gingras A.C., Honkanen R.E. Label-free quantitative proteomics and SAINT analysis enable interactome mapping for the human Ser/Thr protein phosphatase 5. Proteomics 2011, 11:1508-1516.
62. Falsone S.F., Gesslbauer B., Tirk F., Piccinini A.M., Kungl A.J. A proteomic snapshot of the human heat shock protein 90 interactome. FEBS Lett. 2005, 579:6350-6354.
63. Tsaytler P.A., Krijgsveld J., Goerdayal S.S., Rudiger S., Egmond M.R. Novel Hsp90 partners discovered using complementary proteomic approaches. Cell Stress Chaperones 2009, 14:629-638.
64. Gano J.J., Simon J.A. A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein. Mol. Cell. Proteomics 2010, 9:255-270.
65. Echeverria P.C., Figueras M.J., Vogler M., Kriehuber T., de Miguel N., Deng B., Dalmasso M.C., Matthews D.E., Matrajt M., Haslbeck M., Buchner J., Angel S.O. The Hsp90 co-chaperone p23 of Toxoplasma gondii: identification, functional analysis and dynamic interactome determination. Mol. Biochem. Parasitol. 2010, 172:129-140.
66. Pavithra S.R., Kumar R., Tatu U. Systems analysis of chaperone networks in the malarial parasite Plasmodium falciparum. PLoS Comput. Biol. 2007, 3:1701-1715.
67. LaCount D.J., Vignali M., Chettier R., Phansalkar A., Bell R., Hesselberth J.R., Schoenfeld L.W., Ota I., Sahasrabudhe S., Kurschner C., Fields S., Hughes R.E. A protein interaction network of the malaria parasite Plasmodium falciparum. Nature 2005, 438:103-107.
68. Garcia-Descalzo L., Alcazar A., Baquero F., Cid C. Identification of in vivo HSP90-interacting proteins reveals modularity of HSP90 complexes is dependent on the environment in psychrophilic bacteria. Cell Stress Chaperones 2011, 16:203-218.
69. Falsone S.F., Gesslbauer B., Rek A., Kungl A.J. A proteomic approach towards the Hsp90-dependent ubiquitinylated proteome. Proteomics 2007, 7:2375-2383.
70. Schumacher J.A., Crockett D.K., Elenitoba-Johnson K.S., Lim M.S. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells. Proteomics 2007, 7:2603-2616.
71. Song D., Chaerkady R., Tan A.C., Garcia-Garcia E., Nalli A., Suarez-Gauthier A., Lopez-Rios F., Zhang X.F., Solomon A., Tong J., Read M., Fritz C., Jimeno A., Pandey A., Hidalgo M. Antitumor activity and molecular effects of the novel heat shock protein 90 inhibitor, IPI-504, in pancreatic cancer. Mol. Cancer Ther. 2008, 7:3275-3284.
72. Park M.S., Chu F., Xie J., Wang Y., Bhattacharya P., Chan W.K. Identification of cyclophilin-40-interacting proteins reveals potential cellular function of cyclophilin-40. Anal. Biochem. 2011, 410:257-265.
73. Song H.O., Lee W., An K., Lee H.S., Cho J.H., Park Z.Y., Ahnn J. C. elegans STI-1, the homolog of Sti1/Hop, is involved in aging and stress response. J. Mol. Biol. 2009, 390:604-617.
74. Chadli A., Felts S.J., Toft D.O. GCUNC45 is the first Hsp90 co-chaperone to show alpha/beta isoform specificity. J. Biol. Chem. 2008, 283:9509-9512.
75. Grad I., Cederroth C.R., Walicki J., Grey C., Barluenga S., Winssinger N., De Massy B., Nef S., Picard D. The molecular chaperone Hsp90alpha is required for meiotic progression of spermatocytes beyond pachytene in the mouse. PLoS One 2010, 5:e15770.
76. Kunisawa J., Shastri N. Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 2006, 24:523-534.
77. Bouchier-Hayes L., Oberst A., McStay G.P., Connell S., Tait S.W., Dillon C.P., Flanagan J.M., Beere H.M., Green D.R. Characterization of cytoplasmic caspase-2 activation by induced proximity. Mol. Cell 2009, 35:830-840.
78. Li W., Li Y., Guan S., Fan J., Cheng C.F., Bright A.M., Chinn C., Chen M., Woodley D.T. Extracellular heat shock protein-90alpha: linking hypoxia to skin cell motility and wound healing. EMBO J. 2007, 26:1221-1233.
79. Metchat A., Akerfelt M., Bierkamp C., Delsinne V., Sistonen L., Alexandre H., Christians E.S. Mammalian heat shock factor 1 is essential for oocyte meiosis and directly regulates Hsp90alpha expression. J. Biol. Chem. 2009, 284:9521-9528.
80. Scammell J.G., Denny W.B., Valentine D.L., Smith D.F. Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen. Comp. Endocrinol. 2001, 124:152-165.
81. Reynolds P.D., Ruan Y., Smith D.F., Scammell J.G. Glucocorticoid resistance in the squirrel monkey is associated with overexpression of the immunophilin FKBP51. J. Clin. Endocrinol. Metab. 1999, 84:663-669.
82. Sananes N., Baulieu E.E., Le Goascogne C. Stage-specific expression of the immunophilin FKBP59 messenger ribonucleic acid and protein during differentiation of male germ cells in rabbits and rats. Biol. Reprod. 1998, 58:353-360.
83. Uma S., Barret D.J., Matts R.L. Changes in the expression of the heme-regulated eIF-2 alpha kinase and heat shock proteins in rabbit reticulocytes maturing during recovery from anemia. Exp. Cell Res. 1998, 238:273-282.
84. McDowell C.L., Bryan Sutton R., Obermann W.M. Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue. Int. J. Biol. Macromol. 2009, 45:310-314.
85. Nirmalanandhan V.S., Duren A., Hendricks P., Vielhauer G., Sittampalam G.S. Activity of anticancer agents in a three-dimensional cell culture model. Assay Drug Dev. Technol. 2010, 8:581-590.
86. Koppenol W.H., Bounds P.L., Dang C.V. Otto Warburg's contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 2011, 11:325-337.
87. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
88. Okiyoneda T., Barriere H., Bagdany M., Rabeh W.M., Du K., Hohfeld J., Young J.C., Lukacs G.L. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 2010, 329:805-810.
89. Sun F., Mi Z., Condliffe S.B., Bertrand C.A., Gong X., Lu X., Zhang R., Latoche J.D., Pilewski J.M., Robbins P.D., Frizzell R.A. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia. FASEB J. 2008, 22:3255-3263.
90. Wang X., Venable J., LaPointe P., Hutt D.M., Koulov A.V., Coppinger J., Gurkan C., Kellner W., Matteson J., Plutner H., Riordan J.R., Kelly J.W., Yates J.R., Balch W.E. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 2006, 127:803-815.
91. Ficker E., Dennis A.T., Wang L., Brown A.M. Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG. Circ. Res. 2003, 92:e87-e100.
92. Meimaridou E., Gooljar S.B., Ramnarace N., Anthonypillai L., Clark A.J., Chapple J.P. The cytosolic chaperone Hsc70 promotes traffic to the cell surface of intracellular retained Melanocortin-4 receptor mutants. Mol. Endocrinol. 2011, published ahead of print June 30.
93. Echeverria P.C., Picard D. Molecular chaperones, essential partners of steroid hormone receptors for activity and mobility. Biochim. Biophys. Acta 2010, 1803:641-649.
94. Echtenkamp F.J., Zelin E., Oxelmark E., Woo J.I., Andrews B.J., Garabedian M., Freeman B.C. Global functional map of the p23 molecular chaperone reveals an extensive cellular network. Mol. Cell 2011, 43:229-241.
95. Pratt W.B., Galigniana M.D., Harrell J.M., DeFranco D.B. Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell. Signal. 2004, 16:857-872.
96. Galigniana M.D., Echeverria P.C., Erlejman A.G., Piwien-Pilipuk G. Role of molecular chaperones and TPR-domain proteins in the cytoplasmic transport of steroid receptors and their passage through the nuclear pore. Nucleus 2010, 1:299-308.
97. Zheng M., Cierpicki T., Burdette A.J., Utepbergenov D., Janczyk P.L., Derewenda U., Stukenberg P.T., Caldwell K.A., Derewenda Z.S. Structural features and chaperone activity of the NudC protein family. J. Mol. Biol. 2011, 409:722-741.
98. Zhu X.J., Liu X., Jin Q., Cai Y., Yang Y., Zhou T. The L279P mutation of nuclear distribution gene C (NudC) influences its chaperone activity and lissencephaly protein 1 (LIS1) stability. J. Biol. Chem. 2010, 285:29903-29910.
99. Yang Y., Yan X., Cai Y., Lu Y., Si J., Zhou T. NudC-like protein 2 regulates the LIS1/dynein pathway by stabilizing LIS1 with Hsp90. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3499-3504.
100. Zhou T., Zimmerman W., Liu X., Erikson R.L. A mammalian NudC-like protein essential for dynein stability and cell viability. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9039-9044.
101. Faircloth L.M., Churchill P.F., Caldwell G.A., Caldwell K.A. The microtubule-associated protein, NUD-1, exhibits chaperone activity in vitro. Cell Stress Chaperones 2009, 14:95-103.
102. Riera J., Lazo P.S. The mammalian NudC-like genes: a family with functions other than regulating nuclear distribution. Cell. Mol. Life Sci. 2009, 66:2383-2390.
103. Srikakulam R., Liu L., Winkelmann D.A. Unc45b forms a cytosolic complex with Hsp90 and targets the unfolded myosin motor domain. PLoS One 2008, 3:e2137.
104. Liu L., Srikakulam R., Winkelmann D.A. Unc45 activates Hsp90-dependent folding of the myosin motor domain. J. Biol. Chem. 2008, 283:13185-13193.
105. Mishra M., D'Souza M., V, Chang K.C., Huang Y., Balasubramanian M.K. Hsp90 protein in fission yeast Swo1p and UCS protein Rng3p facilitate myosin II assembly and function. Eukaryot. Cell 2005, 4:567-576.
106. Immormino R.M., Metzger L.E.T., Reardon P.N., Dollins D.E., Blagg B.S., Gewirth D.T. Different poses for ligand and chaperone in inhibitor-bound Hsp90 and GRP94: implications for paralog-specific drug design. J. Mol. Biol. 2009, 388:1033-1042.
107. McLaughlin M., Vandenbroeck K. The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?. Br. J. Pharmacol. 2011, 162:328-345.
108. Vogen S., Gidalevitz T., Biswas C., Simen B.B., Stein E., Gulmen F., Argon Y. Radicicol-sensitive peptide binding to the N-terminal portion of GRP94. J. Biol. Chem. 2002, 277:40742-40750.
109. Frese C.K., Altelaar A.F., Hennrich M.L., Nolting D., Zeller M., Griep-Raming J., Heck A.J., Mohammed S. Improved peptide identification by targeted fragmentation using CID, HCD and ETD on an LTQ-Orbitrap Velos. J. Proteome Res. 2011, 10:2377-2388.
110. Trepel J., Mollapour M., Giaccone G., Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat. Rev. Cancer 2010, 10:537-549.